Urinary Bladder Neoplasms
"Urinary Bladder Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the URINARY BLADDER.
| Descriptor ID |
D001749
|
| MeSH Number(s) |
C04.588.945.947.960 C12.758.820.968 C12.777.829.813 C13.351.937.820.945 C13.351.968.829.707
|
| Concept/Terms |
Urinary Bladder Neoplasms- Urinary Bladder Neoplasms
- Neoplasm, Urinary Bladder
- Urinary Bladder Neoplasm
- Neoplasms, Bladder
- Bladder Neoplasms
- Bladder Neoplasm
- Neoplasm, Bladder
- Bladder Tumors
- Bladder Tumor
- Tumor, Bladder
- Tumors, Bladder
Urinary Bladder Cancer- Urinary Bladder Cancer
- Cancer, Urinary Bladder
- Malignant Tumor of Urinary Bladder
- Cancer of the Bladder
- Bladder Cancer
- Bladder Cancers
- Cancer, Bladder
- Cancer of Bladder
|
Below are MeSH descriptors whose meaning is more general than "Urinary Bladder Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder Neoplasms".
This graph shows the total number of publications written about "Urinary Bladder Neoplasms" by people in this website by year, and whether "Urinary Bladder Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 8 | 2 | 10 |
| 1995 | 8 | 4 | 12 |
| 1996 | 13 | 0 | 13 |
| 1997 | 13 | 4 | 17 |
| 1998 | 15 | 3 | 18 |
| 1999 | 14 | 3 | 17 |
| 2000 | 17 | 5 | 22 |
| 2001 | 31 | 1 | 32 |
| 2002 | 20 | 1 | 21 |
| 2003 | 43 | 3 | 46 |
| 2004 | 33 | 9 | 42 |
| 2005 | 35 | 2 | 37 |
| 2006 | 64 | 1 | 65 |
| 2007 | 55 | 1 | 56 |
| 2008 | 60 | 1 | 61 |
| 2009 | 47 | 4 | 51 |
| 2010 | 59 | 5 | 64 |
| 2011 | 29 | 2 | 31 |
| 2012 | 45 | 1 | 46 |
| 2013 | 43 | 3 | 46 |
| 2014 | 53 | 3 | 56 |
| 2015 | 35 | 5 | 40 |
| 2016 | 46 | 2 | 48 |
| 2017 | 37 | 1 | 38 |
| 2018 | 48 | 1 | 49 |
| 2019 | 51 | 1 | 52 |
| 2020 | 59 | 5 | 64 |
| 2021 | 68 | 2 | 70 |
| 2022 | 50 | 0 | 50 |
| 2023 | 56 | 1 | 57 |
| 2024 | 28 | 6 | 34 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urinary Bladder Neoplasms" by people in Profiles.
-
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial. JCO Precis Oncol. 2024 Nov; 8:e2400287.
-
Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer. JCI Insight. 2024 Sep 10; 9(17).
-
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer. Cancer Res Commun. 2024 Sep 01; 4(9):2444-2453.
-
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics. Nat Commun. 2024 Aug 25; 15(1):7312.
-
Novel therapeutic regimens in previously untreated metastatic urothelial carcinoma: A systematic review and bayesian network meta-analysis. Urol Oncol. 2024 Nov; 42(11):361-369.
-
Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer. Nat Commun. 2024 Aug 02; 15(1):6538.
-
Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study. JCO Precis Oncol. 2024 Aug; 8:e2400200.
-
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial. Eur Urol. 2024 Oct; 86(4):297-300.
-
Reply: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Gu?rin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. J Urol. 2024 Oct; 212(4):625.
-
Challenging the Paradigm of "BCG-unresponsive" Bladder Cancer: Does Additional Bacillus Calmette-Gu?rin Have an Effect? Eur Urol. 2024 Oct; 86(4):366-368.